In this Pharmaceutical Market Europe article, Derek Ansel, VP, Therapeutic Strategy Lead, Rare Disease, explores the importance of global collaboration and unified clinical trials for solving rare disease challenges to expedite patients’ access to life-changing therapies. Read more here.
